We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Novagali Pharma SA, a privately-held biopharmaceutical company that develops novel ophthalmic products announced today it has secured EUR26 million in a new financing round involving participation of new and existing investors.
Estrogen-only hormone therapy does not raise the risk of breast cancer for menopausal women, according to research conducted by the Women's Health Initiative (WHI), an endeavor of the National Institutes of Health.
UK-based AstraZeneca and Array BioPharma, headquartered in Colorado, have selected a third compound for their small molecule MEK anticancer program, the companies have reported. This triggered a $1 million milestone payment from AstraZeneca to Array.
New Jersey-based Techedge has acquired China BioPharma (CBP), which has majority ownership rights to Tianyuan Bio-pharmaceuticals, headquartered in Zhejiang Province, China.
PsychoGenics Inc., Tarrytown, NY and Sosei Co. Ltd., Japan, have entered into a drug discovery collaboration combining Sosei's Drug Reprofiling Platform and PsychoGenics' proprietary Drug Discovery Systems.
With the estimated number of people affected by the infectious eye disease, blinding trachoma, dropping from 360 million people to 80 million over the past 21 years, several more countries are on track to eliminate the scourge, the United Nations health agency announced today.
Array BioPharma Inc. on Monday said it is in line to get a $1 million milestone payment from pharmaceutical company AstraZeneca AB after the companies advanced their continuing partnership in a specific area of cancer research.